Biblio

Export 3138 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
J. Liu, Zhang, X., Yu, C., Duan, Y., Zhuo, J., Cui, Y., Liu, B., Li, K., Jiang, T., and Liu, Y., Impaired Parahippocampus Connectivity in Mild Cognitive Impairment and Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1051-64, 2016.
M. De Belder, Santens, P., Sieben, A., and Fias, W., Impaired Processing of Serial Order Determines Working Memory Impairments in Alzheimer's Disease., J Alzheimers Dis, vol. 59, no. 4, pp. 1171-1186, 2017.
F. Di Lorenzo, Ponzo, V., Motta, C., Bonní, S., Picazio, S., Caltagirone, C., Bozzali, M., Martorana, A., and Koch, G., Impaired Spike Timing Dependent Cortico-Cortical Plasticity in Alzheimer's Disease Patients., J Alzheimers Dis, vol. 66, no. 3, pp. 983-991, 2018.
E. Moyse, Bastin, C., Salmon, E., and Brédart, S., Impairment of Age Estimation from Faces in Alzheimer's Disease., J Alzheimers Dis, 2015.
A. Corvol, Netter, A., Campeon, A., and Somme, D., Implementation of an Occupational Therapy Program for Alzheimer's Disease Patients in France: Patients' and Caregivers' Perspectives., J Alzheimers Dis, vol. 62, no. 1, pp. 157-164, 2018.
N. S. Radhakrishnan, Mufti, M., Ortiz, D., Maye, S. T., Melara, J., Lim, D., Rosenberg, E. I., and Price, C. C., Implementing Delirium Prevention in the Era of COVID-19., J Alzheimers Dis, vol. 79, no. 1, pp. 31-36, 2021.
M. R. BenKhedher, Haddad, M., Fülöp, T., Laurin, D., and Ramassamy, C., Implication of Circulating Extracellular Vesicles-Bound Amyloid-β42 Oligomers in the Progression of Alzheimer's Disease., J Alzheimers Dis, vol. 96, no. 2, pp. 813-825, 2023.
C. Myrum, Nikolaienko, ii, O., Bramham, C. R., Haavik, J., and Zayats, T., Implication of the APP Gene in Intellectual Abilities., J Alzheimers Dis, vol. 59, no. 2, pp. 723-735, 2017.
C. M. Hoffmann, Nianogo, R. A., Yaffe, K., Rosenwohl-Mack, A., Carrasco, A., and Barnes, D. E., Importance of Accounting for Regional Differences in Modifiable Risk Factors for Alzheimer's Disease and Related Dementias: The Case for Tailored Interventions., J Alzheimers Dis, vol. 89, no. 2, pp. 563-570, 2022.
J. Laton, Van Schependom, J., Goossens, J., Wiels, W., Sieben, A., De Deyn, P. Paul, Goeman, J., Streffer, J., van der Zee, J., Martin, J. - J., Van Broeckhoven, C., De Vos, M., Bjerke, M., Nagels, G., and Engelborghs, S., Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study., J Alzheimers Dis, vol. 90, no. 4, pp. 1739-1747, 2022.
S. M. de la Monte, Tong, M., Schiano, I., and Didsbury, J., Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease., J Alzheimers Dis, vol. 55, no. 2, pp. 849-864, 2017.
L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M., Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes., J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
P. Emami Khoonsari, Shevchenko, G., Herman, S., Remnestål, J., Giedraitis, V., Brundin, R. M., Gunnarsson, M. Degerman, Kilander, L., Zetterberg, H., Nilsson, P., Lannfelt, L., Ingelsson, M., and Kultima, K., Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers., J Alzheimers Dis, vol. 67, no. 2, pp. 639-651, 2019.
T. - S. Lin, Tsai, H. - J., Lee, C. - H., Song, Y. - Q., Huang, R. - S., Hsieh-Li, H. - M., Liang, M. - C., and Lin, Y., An Improved Drugs Screening System Reveals that Baicalein Ameliorates the Aβ/AMPA/NMDA-Induced Depolarization of Neurons., J Alzheimers Dis, vol. 56, no. 3, pp. 959-976, 2017.
J. Colin, Allouche, A., Chauveau, F., Corbier, C., Pauron-Gregory, L., Lanhers, M. - C., Claudepierre, T., Yen, F. T., Oster, T., and Malaplate-Armand, C., Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide., J Alzheimers Dis, vol. 52, no. 3, pp. 975-87, 2016.
J. Wu, Su, Y., Zhu, W., Mallak, N. Jalili, Lepore, N., Reiman, E. M., Caselli, R. J., Thompson, P. M., Chen, K., and Wang, Y., Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding., J Alzheimers Dis, vol. 91, no. 2, pp. 637-651, 2022.
J. Enrique de Ortí, García-Pardo, M. Pilar, Drehmer, E., Cantus, D. Sancho, Rochina, M. Julián, Aguilar, M. Asunción, and Yang, I. Hu, Improvement of Main Cognitive Functions in Patients with Alzheimer's Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study., J Alzheimers Dis, vol. 65, no. 2, pp. 577-587, 2018.
L. Chenoweth, Burley, C., Cook, J., Cheah, S. - L., Reyes, P., Maiden, G., McGuire, J., McCade, D., Brodaty, H., Sukhapure, M., Harrison, F., and Williams, A., Improving Healthcare Quality and Clinical Outcomes for Persons with Dementia in the Sub-Acute Hospital Through Person-Centered Care Practice., J Alzheimers Dis, vol. 98, no. 2, pp. 619-628, 2024.
E. Lehingue, Gueniat, J., Jourdaa, S., Hardouin, J. BenoÎt, Pallardy, A., Courtemanche, H., Rocher, L., Etcharry-Bouyx, F., Auriacombe, S., Mollion, H., Formaglio, M., Rouaud, O., Bretonnière, C., Thomas-Antérion, C., and Boutoleau-Bretonnière, C., Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale., J Alzheimers Dis, vol. 79, no. 4, pp. 1735-1745, 2021.
E. Schartmann, Schemmert, S., Niemietz, N., Honold, D., Ziehm, T., Tusche, M., Elfgen, A., Gering, I., Brener, O., Shah, N. Joni, Langen, K. - J., Kutzsche, J., Willbold, D., and Willuweit, A., In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. 3, pp. 859-873, 2018.
M. Tahmi, Rippon, B., Palta, P., Sherwood, G., Hernandez, G., Soto, L., Ceballos, F., Pardo, M., Laing, K., Igwe, K., He, H., Teresi, J. A., Moreno, H., Razlighi, Q., Brickman, A. M., and Luchsinger, J. A., In Vivo Amyloid, Neurodegeneration, and Verbal Learning in Late Middle-Aged Hispanics., J Alzheimers Dis, vol. 82, no. 1, pp. 317-325, 2021.
S. Libard, Walter, J., and Alafuzoff, I., In vivo Characterization of Biochemical Variants of Amyloid-β in Subjects with Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease Neuropathological Change., J Alzheimers Dis, vol. 80, no. 3, pp. 1003-1012, 2021.
K. Nakaizumi, Ouchi, Y., Terada, T., Yoshikawa, E., Kakimoto, A., Isobe, T., Bunai, T., Yokokura, M., Suzuki, K., and Magata, Y., In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1355-1365, 2018.
W. M. Snow, Dale, R., O'Brien-Moran, Z., Buist, R., Peirson, D., Martin, M., and Albensi, B. C., In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging., J Alzheimers Dis, vol. 58, no. 3, pp. 841-853, 2017.
Y. Chen, Lim, P., Rogers, K. A., Rutt, B. K., and Ronald, J. A., In Vivo MRI of Amyloid Plaques in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. 3, pp. 911-923, 2018.

Pages